Analysis of association between bleomycin hydrolase and apolipoprotein E polymorphism in Alzheimer's disease

Neurol Sci. 2010 Dec;31(6):687-91. doi: 10.1007/s10072-010-0234-4. Epub 2010 Mar 3.

Abstract

Alzheimer's disease (AD) is the leading cause of dementia. Several studies indicate a possible relationship between different genes and Alzheimer's disease. To further investigate, we have analyzed the association between the bleomycin hydrolase (BLMH) and apolipoprotein E (ApoE) polymorphisms in 93 AD patients and age- and sex-matched 113 controls from the Tunisian population. The frequency of ApoE epsilon 4 allele was found to differ significantly in AD patients compared to the control [29.5% vs. 8.8 (χ (2) = 26, df = 1, p < 0.001)] leading to an increased risk of AD in subjects with this allele (OR = 3.29, 95% CI = 1.7-6.5; p = 0.001]. This risk was found to decrease from OR = 8.4, CI = 3.3-23; p < 0.001 in subjects less than 75 years old to OR = 1.2, CI = 1.031-14; p = 0.0297 in subjects 75 years and older. No association was observed between carrying the BLMH-G genotype and AD in ε4 negative or positive subjects.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / enzymology*
  • Alzheimer Disease / genetics*
  • Apolipoprotein E4 / genetics
  • Apolipoproteins E / genetics*
  • Cysteine Endopeptidases / genetics*
  • Female
  • Genetic Carrier Screening
  • Genetic Predisposition to Disease / genetics*
  • Humans
  • Male
  • Polymorphism, Genetic / genetics*
  • Tunisia

Substances

  • Apolipoprotein E4
  • Apolipoproteins E
  • Cysteine Endopeptidases
  • bleomycin hydrolase